Amber List

CRNXCrinetics Pharmaceuticals, Inc.

Healthcare · Biotechnology · mid-cap ($3.9B)
-37.9%
from rolling 252-day high of $57.99 set 2026-01-05 · 143d ago
Current
$36.01
Decline depth
-37.9%
Decline σ
4.2σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$CRNX has been tracked since 2026-03-01. It was down 29.8% from its 52-week high then — now down -37.9%.

That's 13.6 percentage points deeper than the day it joined.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

CRNX qualifies for the Amber List on decline depth.

Decline depth
-37.9%
From rolling 252-day high of $57.99, 143d ago. Past the 30% Amber threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
4.2σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (4.21% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about CRNX.

CRNX qualifies for the Amber List on decline depth — down -37.9% from its rolling 252-day high.

Cross-confirmation: also showing 3/5 bearish time frames.

Cross-confirmation: decline sigma also reads 4.2σ over 20 bars.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2U (red), weekly 1 (red), monthly 3 (red).

Earnings on file: 2026-02-26. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $24.10 35.1% of range 52W high $57.99

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

89 Red List
46 Amber
59 Watch
-35.8% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about CRNX

What people ask.

Why is CRNX on Broken Stocks?

CRNX qualifies for the Amber List on decline depth. It is down -37.9% from its rolling 252-day high of $57.99, set on 2026-01-05 — 143d ago.

Is CRNX a falling knife?

Not by the strict technical definition. CRNX is down -37.9% from its 52-week high, but that high was set 143d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. CRNX is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.

Is CRNX a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is CRNX trading inside its 52-week range?

At $36.01, CRNX sits 35.1% of the way from its 52-week low ($24.10) to its 52-week high ($57.99). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has CRNX been declining?

The current 37.9% decline accrued over 143d, which annualizes to roughly -96.7% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does CRNX compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 89 Red, 46 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -35.8% — CRNX's decline is deeper than the sector median.

Does CRNX's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-02-26) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.